Vytrus Biotech, S.A. (BME:VYT)
19.50
-0.25 (-1.27%)
At close: Apr 28, 2026
Vytrus Biotech Revenue
In the year 2025, Vytrus Biotech had annual revenue of 9.69M EUR with 59.15% growth. Vytrus Biotech had revenue of 3.06M in the half year ending December 31, 2024, with 46.56% growth.
Revenue
9.69M
Revenue Growth
+59.15%
P/S Ratio
15.12
Revenue / Employee
220.28K
Employees
44
Market Cap
146.57M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Grifols | 7.52B |
| Laboratorios Farmaceuticos Rovi | 743.48M |
| Almirall | 1.11B |
| Pharma Mar | 221.39M |
| Clínica Baviera | 304.91M |
| Prim, S.A. | 251.89M |
| Atrys Health | 144.31M |
| Laboratorio Reig Jofre | 336.68M |